Question follow-through · 10228
Meningitis: Vaccination
To ask the Secretary of State for Health and Social Care, whether he has made an assessment of the potential merits of expanding eligibility for the MenB vaccination programme to students aged 26 and older.
About this written question
A written question asks a government minister for information in writing. Parliament publishes the question and any answer.
- Answering body
- Department of Health and Social Care
- Tabled
- 16 Jun 2026
- Target answer date
- 18 Jun 2026
- Answer
- 24 Jun 2026 · 8 calendar days after tabling
Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.
More questions by this MP on Health and care
- Diethylstilbestrol: Side Effects · 23 Jun 2026
- Diethylstilbestrol · 23 Jun 2026
- Cerebrospinal Fluid: Medical Treatments · 8 Jul 2026
- Cerebrospinal Fluid: Medical Treatments · 8 Jul 2026
- Cancer: Diagnosis · 13 Jul 2026
Shared topic keywords suggest a connection; they do not establish a follow-up.
Votes on this topic
- Terminally Ill Adults (End of Life) Bill: Second Reading · 11 Sept 2026
- Health Bill: Report Stage: Amendment 1 · 8 Sept 2026
- Health Bill: Report Stage: New Clause 143 · 8 Sept 2026
These Commons divisions share a topic label. The question did not necessarily lead to a vote.
Recorded timeline
16 Jun 2026
Question tabled
To ask the Secretary of State for Health and Social Care, whether he has made an assessment of the potential merits of expanding eligibility for the MenB vaccination programme to students aged 26 and older.
18 Jun 2026
Target answer date
Date supplied by the official written-questions record.
24 Jun 2026
Answer published
On 12 June 2026, we announced a one-off, time-limited meningococcal group B (MenB) immunisation programme to protect those at highest immediate risk of MenB disease this autumn.People currently in the Year 13 age group in England and Wales, those born fro...
Official data retrieved 28 Sept 2026.
Later records
Possible follow-up questions
Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.
Diethylstilbestrol: Side Effects
23 Jun 2026 · To ask the Secretary of State for Health and Social Care, if he would hold a public inquiry into the effects of diethylstilbestrol.
Diethylstilbestrol
23 Jun 2026 · To ask the Secretary of State for Health and Social Care, what training healthcare professionals are given on the impacts of diethylstilbestrol.
Cerebrospinal Fluid: Medical Treatments
8 Jul 2026 · To ask the Secretary of State for Health and Social Care, what steps he has taken to help improve NHS (a) diagnosis and (b) treatment pathways of patients suffering a cerebrospinal fluid (CSF) leak.
Cerebrospinal Fluid: Medical Treatments
8 Jul 2026 · To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of developing a nationally coordinated (a) diagnosis pathway and (b) specialist service for patients with a suspected cerebrospinal fluid (CSF) l
Cancer: Diagnosis
13 Jul 2026 · To ask the Secretary of State for Health and Social Care, what the (a) shortest, (b) median, and (c) longest time was for patients to receive the results of a suspected cancer biopsy for each of the last 12 months, broken down by hospital trust.
Nurses: Pay
28 Aug 2026 · To ask the Secretary of State for Health and Social Care, what assessment she has made of the potential merits of ensuring NHS General Practice nurses have ringfenced salary increases, in line with the arrangements for General Practitioners pay.
Nurses: Pay
28 Aug 2026 · To ask the Secretary of State for Health and Social Care, if she will review whether nurses employed by NHS General Practices should be included in the Agenda for Change published pay rates.
Prescriptions: Regulation
28 Aug 2026 · To ask the Secretary of State for Health and Social Care, what steps she is taking to reduce medicine over prescribing.
Brain: Tumours
28 Aug 2026 · To ask the Secretary of State for Health and Social Care, whether she will make representations to NuvationBio to encourage access to the SIGMA Phase 3 trial of Safusideniv for eligible patients at UK hospitals.